Continuous subcutaneous insulin infusion (CSII or ‘insulin pumps’) therapy is recommended as a treatment option for adults and children 16 years and older with Type 1 diabetes mellitus
Across Leicester, Leicestershire and Rutland there are over 150 adult patients, currently having insulin pump therapy, with enormous benefits. Our assessment criteria for inclusion of patients is the following:
Our consultant diabetologists, and diabetes specialist nurse.(DSN) carry out the assessment for insulin pump therapy.
The patient is offered intense education input prior to being recommended for pump therapy, for example DAFNE, which is now available and in mainstream funding.
Following a positive assessment, the patient is then offered a trial of a pump from Roche which are the preferred suppliers in Leicestershire, although alternative suppliers are available.
Once this trial of 1 month is achieved, the patient is regularly followed up to assess biomedical measures and quality of life.
Link to the NICE website to Technology Appraisal Guidance, Guidance on the Use of Continuous Subcutaneous Insulin Infusion for Diabetes.